Financials Curiox Biosystems Co., Ltd

Equities

A445680

KR7445680002

Biotechnology & Medical Research

End-of-day quote Korea S.E. 23:00:00 28/05/2024 BST 5-day change 1st Jan Change
46,100 KRW -5.14% Intraday chart for Curiox Biosystems Co., Ltd -9.78% -8.35%

Valuation

Fiscal Period: December 2023
Capitalization 1 403,531
Enterprise Value (EV) 1 386,587
P/E ratio -35.8 x
Yield -
Capitalization / Revenue 59.4 x
EV / Revenue 57 x
EV / EBITDA -44.9 x
EV / FCF -104 x
FCF Yield -0.96%
Price to Book 7.63 x
Nbr of stocks (in thousands) 8,022
Reference price 2 50,300
Announcement Date 20/03/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023
Net sales 1 6,788
EBITDA 1 -8,605
EBIT 1 -10,557
Operating Margin -155.53%
Earnings before Tax (EBT) 1 -10,211
Net income 1 -10,040
Net margin -147.92%
EPS 2 -1,406
Free Cash Flow 1 -3,723
FCF margin -54.85%
FCF Conversion (EBITDA) -
FCF Conversion (Net income) -
Dividend per Share -
Announcement Date 20/03/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023
Net Debt 1 -
Net Cash position 1 16,944
Leverage (Debt/EBITDA) -
Free Cash Flow 1 -3,723
ROE (net income / shareholders' equity) -20.8%
ROA (Net income/ Total Assets) -12.4%
Assets 1 80,974
Book Value Per Share 2 6,591
Cash Flow per Share 2 2,232
Capex 1 212
Capex / Sales 3.12%
Announcement Date 20/03/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. A445680 Stock
  4. Financials Curiox Biosystems Co., Ltd